1-8 of 8
Harry W. Findley, PhD
Close
Sort by
Journal Articles

Targeting CD22 in Childhood B-Precursor Acute Lymphoblastic Leukemia (Pre-B ALL): Pre-Clinical Studies and Phase I Trial of the Anti-CD22 Immunotoxin CAT-3888 (BL22).

Alan S. Wayne, MD, Harry W. Findley, PhD, Glen Lew, MD, Yachna Ahuja, BS, Lubing Gu, MD, Maryalice Stetler-Stevenson, MD, PhD, Robert J. Kreitman, MD, Ira Pastan, MD
Journal: Blood
Blood (2007) 110 (11): 855.
https://doi.org/10.1182/blood.V110.11.855.855
Published: 2007
Journal Articles

The MDM2 Antagonist Nutlin-3 Is a Potent Inducer of Apoptosis in Pediatric Acute Lymphoblastic Leukemia Cells with Wild-Type p53 and Overexpression of MDM2.

Lubing Gu, MD, Ningxi Zhu, MD, PhD, Harry W. Findley, PhD, Muxiang Zhou, MD
Journal: Blood
Blood (2007) 110 (11): 4277.
https://doi.org/10.1182/blood.V110.11.4277.4277
Published: 2007
Journal Articles

Contribution of STAT3 to Activation of Survivin by Granulocyte-Macrophage Colony-Stimulating Factor in CD34+ Cells.

Lubing Gu, MD, Kuang-Yueh Chiang, MD, Ningxi Zhu, MD,PhD, Harry W. Findley, PhD, Muxiang Zhou, MD
Journal: Blood
Blood (2006) 108 (11): 4202.
https://doi.org/10.1182/blood.V108.11.4202.4202
Published: 2006
Journal Articles

Expression of Inhibitor-of-Apoptosis Protein (IAP) Livin in Pediatric Acute Lymphoblastic Leukemia (ALL) Cells.

Anindya Dasgupta, PhD, Lubing Gu, MD, Carlos S. Alvarado, MD, Muxiang Zhou, MD, Harry W. Findley, PhD
Journal: Blood
Blood (2005) 106 (11): 4526.
https://doi.org/10.1182/blood.V106.11.4526.4526
Published: 2005
Journal Articles

Endogenous TNFα Mediates Cell Survival and Chemotherapy Resistance by Activating the PI3K/Akt Pathway in Childhood Acute Lymphoblastic Leukemia.

Lubing Gu, MD, Harry W. Findley, PhD, Ningxi Zhu, MD, PhD, Muxiang Zhou, MD
Journal: Blood
Blood (2005) 106 (11): 4551.
https://doi.org/10.1182/blood.V106.11.4551.4551
Published: 2005
Journal Articles

Vitamin K3 Selectively Induces Apoptosis in Acute Lymphoblastic Leukemia Cells with Constitutive Activation of IKKα/NF-kB Activation.

Ningxi Zhu, MD, PhD, Lubing Gu, MD, Harry W. Findley, PhD, Kuang-Yueh Chiang, MD, Muxiang Zhou, MD
Journal: Blood
Blood (2005) 106 (11): 859.
https://doi.org/10.1182/blood.V106.11.859.859
Published: 2005
Journal Articles

Loss of PTEN Expression Induces NF-kB Via PI3K/Akt Pathway Involving Resistance to Chemotherapy in Acute Lymphoblastic Leukemia Cell Lines.

Lubing Gu, MD, Ningxi Zhu, MD, PhD, Harry W. Findley, PhD, Muxiang Zhou, MD
Journal: Blood
Blood (2004) 104 (11): 4438.
https://doi.org/10.1182/blood.V104.11.4438.4438
Published: 2004
Journal Articles

An Alternatively Spliced Survivin Variant Is Positively Regulated by p53 and Sensitizes Leukemia Cells to Chemotherapy.

Ningxi Zhu, MD, PhD, Lubing Gu, MD, Harry W. Findley, PhD, Fengzhi Li, PhD, Muxiang Zhou, MD
Journal: Blood
Blood (2004) 104 (11): 3497.
https://doi.org/10.1182/blood.V104.11.3497.3497
Published: 2004